Skip to main content

MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

21 Nov 2026 Evaluate
Sun Pharmaceutical Industries has informed that pursuant to SEBI Circular no. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30 January 2026, the Company has published newspaper advertisements [All editions of Financial Express (in English) and Ahmedabad Edition of Financial Express (in Gujarati)] on 21 November 2026 containing information about the opening of Special Window, for a period of one year from 05 February 2026 to 04 February 2027, for transfer of physical shares, which were sold/purchased prior to 01 April 2019, including such transfer requests which were submitted earlier and were rejected or returned or not attended to due to deficiency in the documents/ process/or otherwise. Copies of newspaper clippings are attached as Annexure-A, which is also available on the Company’s website at www.sunpharma.com In addition to the above, the Company will publish posts on social media platforms, viz. X, LinkedIn, and Facebook regarding the aforementioned special window.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..